Citigroup’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.7K | Buy |
+3,631
| New | +$27.7K | ﹤0.01% | 4269 |
|
|
2025
Q1 | – | Sell |
-111,208
| Closed | -$500K | – | 4969 |
|
|
2024
Q4 | $500K | Sell |
111,208
-5,522
| -5% | -$24.8K | ﹤0.01% | 3023 |
|
|
2024
Q3 | $323K | Sell |
116,730
-19,014
| -14% | -$52.7K | ﹤0.01% | 3276 |
|
|
2024
Q2 | $464K | Buy |
135,744
+130,735
| +2,610% | +$447K | ﹤0.01% | 2746 |
|
|
2024
Q1 | $27.1K | Buy |
5,009
+4,151
| +484% | +$22.5K | ﹤0.01% | 4184 |
|
|
2023
Q4 | $4.65K | Buy |
+858
| New | +$4.65K | ﹤0.01% | 4567 |
|